United States · FDA National Drug Code directory
mesalamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68682-113_0ce2b1db-0b45-4548-e063-6294a90a84f1
- Product NDC
- 68682-113
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- mesalamine
- Labeler
- Oceanside Pharmaceuticals
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20180719
- Source listing expiry
- 20261231
Source-listed ingredients
- MESALAMINE — 375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (68682-113-20) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 68682-113-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →